flupenthixol has been researched along with Invasiveness, Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apolito, K; Chen, S; Hait, WN; Miletti-González, KE; Muthukumaran, N; Rodríguez-Rodríguez, L; Saglimbeni, GN; Shih, WJ; Wu, X; Yang, J | 1 |
Hait, WN; Liao, J; Medina, DJ; Vassil, AD; Yang, GY; Yang, JM | 1 |
2 other study(ies) available for flupenthixol and Invasiveness, Neoplasm
Article | Year |
---|---|
The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Membrane; Cell Movement; Drug Resistance, Neoplasm; Female; Flupenthixol; Humans; Hyaluronan Receptors; Immunoprecipitation; Neoplasm Invasiveness; Neoplasms; RNA Interference; Transfection | 2005 |
Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cell Movement; Disease Progression; Drug Resistance, Neoplasm; Female; Flupenthixol; Humans; Hydrogen-Ion Concentration; Leukemia P388; Liver Neoplasms; Mechlorethamine; Mice; Neoplasm Invasiveness; Neoplasm Transplantation; Paclitaxel; Survival Rate; Tumor Cells, Cultured; Vincristine | 1999 |